BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 7188126)

  • 1. [Clinical and hemodynamic evaluation of the action of pentoxifylline in patients with obstructive arteriopathy of the lower extremities].
    Zaccaria A; Antonini M; Marciani A; Taurino M; Speziale F; Spartera C
    Ric Clin Lab; 1981; 11 Suppl 1():381-6. PubMed ID: 7188126
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with pentoxifylline in chronic obliterative disease of the leg arteries in hospitalized and ambulatory patients].
    Sondern W; Leube G
    Med Welt; 1979 Sep; 30(37):1367-9. PubMed ID: 502814
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical aspects of hemorrheology in the aged: possibility of prevention and therapy].
    Feruglio FS; Ponte E
    Ric Clin Lab; 1981; 11 Suppl 1():373-9. PubMed ID: 7188125
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical pharmacology of vasoactive substances: study on pentoxifylline].
    Pupita F; Rotatori P; Frausini G
    Ric Clin Lab; 1981; 11 Suppl 1():293-302. PubMed ID: 7188116
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of chronic arterial bloodcirculation interference (author's transl)].
    Mund-Hoym WD
    Schweiz Rundsch Med Prax; 1978 Oct; 67(43):1593-9. PubMed ID: 714861
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy of arterial diseases. A study with Trental 400].
    Tannenberg G
    Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical results of pentoxifylline use in a community peripheral vascular surgical practice.
    Smith MA; Fish RC
    Monogr Atheroscler; 1990; 15():27-9. PubMed ID: 2296248
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
    Benignetti G; Fabbri F; Benvenuti C
    Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of circulation disorders with pentoxifylline. A double-blind study with Trental].
    Tonak J; Knecht H; Groitl H
    Med Monatsschr; 1977 Oct; 31(10):467-72. PubMed ID: 337089
    [No Abstract]   [Full Text] [Related]  

  • 10. [Training by walking and drug therapy of peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
    Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
    von Westphalen JG
    MMW Munch Med Wochenschr; 1977 Jul; 119(26):901-4. PubMed ID: 408616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of pentoxifylline (BL 191) in the treatment of peripheral blood circulation disorders].
    Cavaller JM; Samper JC
    Med Monatsschr; 1976 Jul; 30(7):323-6. PubMed ID: 790140
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of arterial diseases with trental 400. Results of a double-blind study].
    Völker D
    Med Welt; 1978 Aug; 29(32):1244-7. PubMed ID: 672594
    [No Abstract]   [Full Text] [Related]  

  • 14. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
    Angelkort B; Doppelfeld E
    Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
    Angelkort B
    Med Welt; 1979 Aug; 30(34):1239-43. PubMed ID: 491921
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of trophic ulcers of the lower extremities with Trental-400].
    Koshkin VM; Bogdanets LI; Makarova LD
    Khirurgiia (Mosk); 1996; (1):49-51. PubMed ID: 8683922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and hemorrheologic effects of pentoxifylline in patients with obliterative arteriopathy of the legs].
    Vaya A; Martínez M; Carbonell P; Aznar J
    Angiologia; 1987; 39(6):262-8. PubMed ID: 3425972
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
    Schweiger H; Ortmeier CJ
    Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
    Ehrly AM
    J Med; 1979; 10(5):331-8. PubMed ID: 294470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.